BAMS
IBB icon

Bellevue Asset Management (Switzerland)’s iShares Biotechnology ETF IBB Stock Holding History

Bellevue Asset Management (Switzerland)’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$846K Hold
7,500
– – 0.13% 106
2015
Q3 		$758K Buy
+7,500
New +$900K 0.12% 112
2015
Q2 		– Sell
-18,000
Closed -$2.06M – 144
2015
Q1 		$2.06M Buy
+18,000
New +$1.99M 0.29% 85

Other funds holding IBB

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s IBB Position: Q4 2015 in Review

Bellevue Asset Management (Switzerland) held its iShares Biotechnology ETF (IBB) position steady in Q4 2015 at 7,500 shares worth $846K. The position accounts for 0.13% of the portfolio, ranked #106.

Bellevue Asset Management (Switzerland) first reported a position in IBB in Q1 2015 and has held it in 3 quarters since. The position peaked at $2.06M in Q1 2015. 432 funds tracked by Wall St. Rank hold IBB as of Q4 2015.

  • Bellevue Asset Management (Switzerland) held 7,500 shares of iShares Biotechnology ETF worth $846K as of Q4 2015.
  • Bellevue Asset Management (Switzerland) left its iShares Biotechnology ETF share count unchanged in Q4 2015.
  • iShares Biotechnology ETF made up 0.13% of Bellevue Asset Management (Switzerland)'s portfolio in Q4 2015, its #106 holding.
  • Bellevue Asset Management (Switzerland) first reported a position in iShares Biotechnology ETF in Q1 2015 and has held it in 3 quarters since.
  • Bellevue Asset Management (Switzerland)'s iShares Biotechnology ETF position peaked at $2.06M in Q1 2015.
  • 432 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.